Intranasal application of the α2-adrenoceptor agonist BHT-920 produces decongestion in the cat

American Journal of Rhinology

Volumn 15, Issue 6, 2001, Pages 407-415

  McLeod, R L ^a   Erickson, C H ^a   Mingo, G G ^a   Hey, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DECONGESTIVE AGENT; OXYMETAZOLINE; PHENYLEPHRINE; TALIPEXOLE; ALPHA 2 ADRENERGIC RECEPTOR; AZEPINE DERIVATIVE;

ARTICLE; BLOOD PRESSURE MONITORING; CAT; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; MAST CELL; NONHUMAN; NOSE CAVITY; NOSE CONGESTION; RHINOMETRY; ANIMAL; ANIMAL MODEL; BLOOD PRESSURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG POTENTIATION; EVALUATION; HEART RATE; INTRANASAL DRUG ADMINISTRATION; NOSE OBSTRUCTION; NOSE PROVOCATION TEST; TIME;

ADMINISTRATION, INTRANASAL; ANIMALS; AZEPINES; BLOOD PRESSURE; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; MODELS, ANIMAL; NASAL CAVITY; NASAL DECONGESTANTS; NASAL OBSTRUCTION; NASAL PROVOCATION TESTS; OXYMETAZOLINE; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; RHINOMETRY, ACOUSTIC; TIME FACTORS;

EID: 0035543831     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240101500610     Document Type: Article

References (35)

1. Nasal congestion: A review of its etiology, evaluation, and treatment
2. Characterization of α-adrenoceptors in the vasculature of the canine nasal mucosa
3. Adrenoceptors in the control of human nasal mucosal blood flow
4. 1-receptors at pre-capillary resistance vessels of the human nasal mucosa
5. Sympathetic vascular control of the pig nasal mucosa: Adrenoceptor mechanisms in blood flow and volume control
6. Rhinitis medicamentosa: Aspect of pathophysiology and treatment
7. A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies
8. The pharmacology of α-adrenergic decongestants
9. Effects of sustained-release oral phenyl-propanolamine on the nasal mucosa of healthy subjects
10. Cerebral infarction with a single oral dose of phenylpropanolamine
11. Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reports
12. Occurrence of stroke associated with use/abuse of drugs
13. Phenylpropanolamine and the risk of hemorrhagic stroke
14. Allergic rhinitis: Treating the adult
15. Acoustic rhinometry: Evaluation of nasal cavity geometry by acoutic reflection
16. Culture and initial characterization of the secretory response of neoplastic cat mast cells
17. Changes in nasal resistance and nasal geometry using pressure rhinometry in a feline model of nasal congestion
18. Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrine
19. 2-adrenoceptor agonists in isolated rubbed rat aorta
20. 2-autoreceptors in the rabbit pulmonary artery and human saphenous vein
21. 2c-adrenoceptor contractility in human saphenous vein
22. 2-adrenoceptor agonists in pithed rats
23. Bilateral increase in histamine after unilateral nasal allergen challenge
24. Double-blind study of nasal decongestion with oxymetazoline and phenylephrine in asthmatic children with rhinitis
25. Control of nasal vasculature and airflow resistance in the dog
26. Nasal decongestion evaluated by acoustic rhinometry
27. Correlation between nasal obstruction symptoms and objective parameters of acoustic rhinometry and rhinomanometry
28. A new nasal decongestant, A-57219: A comparison with oxymetazoline
29. Nasal decongestion with imidazoline derivatives: Acoustic rhinometry measurements
30. Acoustic rhinometry in the evaluation of nasal obstruction
31. 2-adrenoceptor mediated pressor responses in pithed rats
32. The renaissance of centrally acting antihypertensive drugs
33. Intravenous clonidine infusion in critically ill children: Dose-dependent sedative effects and cardiovascular stability
34. Sedative and physiologic effects of orally administered alpha 2-adrenoceptor agonists and ketamine in cats
35. The effects of increasing plasma concentrations of dexmedetomidine in humans